Coopervision receives FDA approval for its MiSight 1 day contact lens
Coopervision has received approval from the USA Food and Drug Administration (FDA) for its MiSight 1 day contact lens.
This approval has made MiSight the only daily single use contact lens with a CE mark that slows the progression of myopia in children to become FDA approved.
President of CooperVision Daniel G. McBride said: ‘We can’t overstate the importance and potential impact of this landmark decision on children’s vision, especially considering the rise in myopia’s severity and prevalence in the U.S. and worldwide. Eye care professionals who embrace this breakthrough approach will improve the quality of life and eye health for so many children.’
